Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Thomas E. PolenPresident, CEO & Chairman | -20,21k | 404,53k | Derivative Exercise and Sale | 126,16 - 146,35 | 110,16k | - |
| 2026-05-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75,00 | 11,05k | Automatic Disposition | 147,35 | 21,08k | -0,35% |
| 2026-04-27 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -74,00 | 11,24k | Automatic Disposition | 151,94 | 21,16k | -0,35% |
| 2026-04-06 | Ms. Shana Carol NealExec. VP & CPO | -1,15k | 0,00 | Sale to Issuer | - | 23,97k | -4,56% |
| 2026-03-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75,00 | 11,76k | Automatic Disposition | 156,83 | 21,23k | -0,35% |
| 2026-02-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75,00 | 13,64k | Automatic Disposition | 181,84 | 21,31k | -0,35% |
| 2026-02-18 | Mr. Bertram Lee ScottIndependent Director | -953,00 | 174,03k | Verkauf | 182,61 | 36,76k | -2,53% |
| 2026-01-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75,00 | 15,20k | Automatic Disposition | 202,73 | 16,43k | -0,45% |
| 2026-01-21 | Ms. Pamela L. SpiknerInsider | -84,00 | 0,00 | Sale to Issuer | - | 1,83k | -4,38% |
| 2026-01-15 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -3,05k | 125,49k | Derivative Exercise and Sale | 167,91 - 209,00 | 12,10k | - |
| 2026-01-15 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -1,01k | 208,61k | Automatic Disposition | 206,54 | 12,10k | -7,71% |
| 2026-01-03 | Mr. David Michel ShanExec. VP & Chief Integrated Supply Chain Officer | -44,00 | 0,00 | Sale to Issuer | - | 8,93k | -0,49% |
| 2025-12-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -74,00 | 14,51k | Automatic Disposition | 196,08 | 16,51k | -0,45% |
| 2025-12-17 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -629,00 | 123,30k | Automatic Disposition | 196,03 | 13,11k | -4,58% |
| 2025-12-01 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75,00 | 14,50k | Automatic Disposition | 193,36 | 16,58k | -0,45% |
| 2025-11-26 | Mr. David Michel ShanExec. VP & Chief Integrated Supply Chain Officer | -134,00 | 0,00 | Sale to Issuer | - | 8,97k | -1,47% |
| 2025-11-26 | Ms. Shana Carol NealExec. VP & CPO | -2,45k | 0,00 | Sale to Issuer | - | 21,33k | -10,32% |
| 2025-11-26 | Mr. Roland GoetteExec. VP & President of EMEA | -138,00 | 0,00 | Sale to Issuer | - | 18,78k | -0,73% |
| 2025-11-26 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -1,77k | 0,00 | Sale to Issuer | - | 13,73k | -11,41% |
| 2025-11-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -419,00 | 0,00 | Sale to Issuer | - | 16,66k | -2,45% |
| 2025-11-26 | Mr. Christopher J. DelOreficeInsider | -4,25k | 0,00 | Sale to Issuer | - | 22,98k | -15,59% |
| 2025-11-26 | Mr. Richard E. ByrdInsider | -1,72k | 0,00 | Sale to Issuer | - | 13,85k | -11,04% |
| 2025-11-26 | Mr. Thomas E. PolenPresident, CEO & Chairman | -17,42k | 0,00 | Sale to Issuer | - | 105,47k | -14,18% |
| 2025-11-07 | Mr. Bertram Lee ScottIndependent Director | -217,00 | 38,32k | Verkauf | 176,58 | 35,82k | -0,60% |
| 2025-10-27 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -57,00 | 10,60k | Automatic Disposition | 186,01 | 8,25k | -0,69% |
| 2025-09-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -58,00 | 10,50k | Automatic Disposition | 181,03 | 8,30k | -0,69% |
| 2025-09-10 | Dr. Claire M. Fraser-LiggettInsider | -917,00 | 171,94k | Verkauf | 187,50 | 22,23k | -3,96% |
| 2025-09-01 | Mr. Christopher J. DelOreficeInsider | -278,00 | 0,00 | Sale to Issuer | - | 21,22k | -1,29% |
| 2025-09-01 | Mr. Richard E. ByrdInsider | -216,00 | 0,00 | Sale to Issuer | - | 6,74k | -3,11% |
| 2025-08-22 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -57,00 | 11,29k | Automatic Disposition | 197,99 | 8,36k | -0,68% |
| 2025-08-20 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -773,00 | 0,00 | Sale to Issuer | - | 8,42k | -8,41% |
| 2025-08-11 | Mr. Gregory J. HayesIndependent Director | 5,25k | 1,01M | Kauf | 191,57 | 5,25k | - |
| 2025-08-08 | Dr. Claire M. Fraser-LiggettInsider | -863,00 | 165,95k | Verkauf | 192,30 | 23,14k | -3,59% |
| 2025-07-18 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -6,36k | 207,40k | Derivative Exercise and Sale | 147,68 - 181,50 | 4,89k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
